Figure 3.
Cumulative incidence of relapse in the subcohort for the 3 groups based on intensity of asparaginase treatment. NontruncatedandAEA+: 6.7% (95% CI, 6.0-9.7), truncatedmediumIntensity: 9.4% (95% CI, 3.2-15.7), truncatedlowIntensity: 11.9% (95% CI, 6.4-17.4).

Cumulative incidence of relapse in the subcohort for the 3 groups based on intensity of asparaginase treatment. NontruncatedandAEA+: 6.7% (95% CI, 6.0-9.7), truncatedmediumIntensity: 9.4% (95% CI, 3.2-15.7), truncatedlowIntensity: 11.9% (95% CI, 6.4-17.4).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal